rs1535, FADS2

N. diseases: 24
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
High density lipoprotein measurement
1440 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.800 1.000 4 2010 2019
Low density lipoprotein cholesterol measurement
1142 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.800 1.000 3 2012 2019
Colorectal Carcinoma
CUI: C0009402
Disease: Colorectal Carcinoma
1962 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.800 1.000 2 2014 2019
Serum total cholesterol measurement
CUI: C1445957
Disease: Serum total cholesterol measurement
1243 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.800 1.000 2 2012 2017
Triglycerides measurement
CUI: C0202236
Disease: Triglycerides measurement
1418 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.800 1.000 2 2012 2019
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
591 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.800 1.000 1 2010 2010
Serum albumin measurement
CUI: C0523465
Disease: Serum albumin measurement
3282 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 2 2012 2013
Serum HDL cholesterol measurement
CUI: C0428472
Disease: Serum HDL cholesterol measurement
679 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 2 2012 2012
Adenocarcinoma of large intestine
CUI: C1319315
Disease: Adenocarcinoma of large intestine
432 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2019 2019
Chronic Kidney Diseases
CUI: C1561643
Disease: Chronic Kidney Diseases
306 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2018 2018
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
374 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2019 2019
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
370 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2019 2019
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
373 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2019 2019
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
368 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2019 2019
Colorectal Neoplasms
CUI: C0009404
Disease: Colorectal Neoplasms
609 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2019 2019
Inflammatory Bowel Diseases
CUI: C0021390
Disease: Inflammatory Bowel Diseases
605 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2015 2015
Kidney Failure, Chronic
CUI: C0022661
Disease: Kidney Failure, Chronic
425 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2018 2018
Malignant neoplasm of large intestine
375 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2019 2019
Malignant tumor of colon
CUI: C0007102
Disease: Malignant tumor of colon
688 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2019 2019
Phosphatidylcholine measurement
CUI: C0523829
Disease: Phosphatidylcholine measurement
19 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2019 2019
Phospholipid measurement
CUI: C0202177
Disease: Phospholipid measurement
306 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2011 2011
Serum LDL cholesterol measurement
CUI: C0428474
Disease: Serum LDL cholesterol measurement
555 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.700 1.000 1 2012 2012
Congestive heart failure
CUI: C0018802
Disease: Congestive heart failure
165 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.010 1.000 1 2012 2012
Neoplasms
CUI: C0027651
Disease: Neoplasms
1644 0.752 0.240 11 61830500 intron variant A/G snv 0.31 0.010 1.000 1 2017 2017